RedHill Biopharma Ltd - Company Profile
Powered by
All the data and insights you need on RedHill Biopharma Ltd in one report.
- Save hours of research time and resources with
our up-to-date RedHill Biopharma Ltd Strategy Report
- Understand RedHill Biopharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes products and novel small-molecule drugs for the treatment of gastrointestinal diseases and cancer. Partnerships contributed to growth, commercial product portfolio for GI diseases and focus on R&D are its strengths even as history of operating losses could be a cause for concern for the company. RedHill could benefit from its pipeline products, regulatory approvals and market potential: Crohn’s disease. However, high competition, dependence on third parties and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer